CIRQILA (U.S. Trademark Serial Number 79261899) is a United States trademark of Novartis AG. The goods and services include: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma . The correspondent is Maury M. Tepper, III of Tepper & Eyster, PLLC.
This trademark was filed on April 27, 2019 as United States Trademark Application Serial Number 79261899. The trademark application was registered on November 19, 2019 as U.S. Trademark Registration 5911437.
Trademark PTO Status History
July 04, 2022 – NOTIFICATION PROCESSED BY IB
December 22, 2021 – INTERNATIONAL REGISTRATION RENEWED
December 12, 2021 – NOTIFICATION PROCESSED BY IB
August 24, 2021 – NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
August 24, 2021 – DEATH OF INTERNATIONAL REGISTRATION
February 21, 2020 – NOTIFICATION PROCESSED BY IB
January 13, 2020 – FINAL DISPOSITION NOTICE SENT TO IB
January 13, 2020 – FINAL DISPOSITION PROCESSED
View full trademark status information at USPTO
Ownership History
Novartis AG
Novartis AG
Novartis AG
View documents on file at USPTO
File a Trademark or Get Help With Trademark Law
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.